[EN] RAS INHIBITORS, COMPOSITIONS AND METHODS OF USE THEREOF [FR] INHIBITEURS DE RAS, COMPOSITIONS ET PROCÉDÉS D'UTILISATION DE CEUX-CI
摘要:
There is provided a compound of formula (I), and its use for inhibiting RAS (wild type or mutant), for example HRAS, NRAS, and/or KRAS, and for the prevention or treatment of a disease or disorder associated with abnormal RAS activity, for example abnormal RAS activity caused by a mutation in RAS, including cancers with a mutated RAS. (I)
[EN] RAS INHIBITORS, COMPOSITIONS AND METHODS OF USE THEREOF [FR] INHIBITEURS DE RAS, COMPOSITIONS ET PROCÉDÉS D'UTILISATION DE CEUX-CI
摘要:
There is provided a compound of formula (I), and its use for inhibiting RAS (wild type or mutant), for example HRAS, NRAS, and/or KRAS, and for the prevention or treatment of a disease or disorder associated with abnormal RAS activity, for example abnormal RAS activity caused by a mutation in RAS, including cancers with a mutated RAS. (I)
Robust Strategy for Hit-to-Lead Discovery: NMR for SAR
作者:Sacha T. Larda、Yann Ayotte、Maria M. Denk、Paul Coote、Gregory Heffron、David Bendahan、Fatma Shahout、Nicolas Girard、Mustapha Iddir、Patricia Bouchard、Francois Bilodeau、Simon Woo、Luc J. Farmer、Steven R. LaPlante